September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Myeloid-derived VEGF and HIF are dispensable for ocular neovascularisation
Author Affiliations & Notes
  • Sidath Liyanage
    Division of Genetics, UCL Institute of Ophthalmology, London, United Kingdom
  • Alessandro Fantin
    Division of Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom
  • Pilar Villacampa
    Division of Genetics, UCL Institute of Ophthalmology, London, United Kingdom
  • Clemens Lange
    Division of Genetics, UCL Institute of Ophthalmology, London, United Kingdom
    University Eye Hospital Freiburg, Freiburg, Germany
  • Laura Denti
    Division of Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom
  • Enrico Cristante
    Division of Genetics, UCL Institute of Ophthalmology, London, United Kingdom
  • Alexander J Smith
    Division of Genetics, UCL Institute of Ophthalmology, London, United Kingdom
  • Robin R Ali
    Division of Genetics, UCL Institute of Ophthalmology, London, United Kingdom
  • Ulrich F O Luhmann
    Division of Genetics, UCL Institute of Ophthalmology, London, United Kingdom
    F. Hoffmann-La Roche Ltd, Basel, Switzerland
  • James W B Bainbridge
    Division of Genetics, UCL Institute of Ophthalmology, London, United Kingdom
  • Christiana Ruhrberg
    Division of Cell Biology, UCL Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships   Sidath Liyanage, None; Alessandro Fantin, None; Pilar Villacampa, None; Clemens Lange, None; Laura Denti, None; Enrico Cristante, None; Alexander Smith, None; Robin Ali, None; Ulrich Luhmann, None; James Bainbridge, None; Christiana Ruhrberg, None
  • Footnotes
    Support  MRC & Fight for Sight clinician research training fellowship MR/K003003/1
Investigative Ophthalmology & Visual Science September 2016, Vol.57, No Pagination Specified. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Sidath Liyanage, Alessandro Fantin, Pilar Villacampa, Clemens Lange, Laura Denti, Enrico Cristante, Alexander J Smith, Robin R Ali, Ulrich F O Luhmann, James W B Bainbridge, Christiana Ruhrberg; Myeloid-derived VEGF and HIF are dispensable for ocular neovascularisation. Invest. Ophthalmol. Vis. Sci. 201657(12):.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : Ocular neovascularisation (ONV) is a pathological feature of diseases such as diabetic retinopathy and age-related macular degeneration. Myeloid cells are considered an important source of the vascular endothelial growth factor A (VEGF) in mouse models of ONV. By inducing neovascularization in transgenic mouse models using oxygen-induced retinopathy (OIR) and laser-induced choroidal neovascularization (CNV), we investigated the hypothesis that myeloid-derived VEGF and its upstream regulators hypoxia-inducible factor (HIF)-1α and HIF2α are key drivers of ONV.

Methods : The Vegfa+/LacZ reporter and in situ hybridisation (ISH) were used to analyse Vegfa expression. Cre-lox systems used Lysm+/Cre or Tie2-Cre to target myeloid cells for reporter expression with Rosa26Yfp and Rosa26mT/mG or deletion of Hif1afl/fl, Hif2afl/fl orVegfafl/fl. Established OIR and CNV protocols were performed with littermate controls. Anti-isolectin B4 staining on P17 retinal flatmounts was used to identify avascular (AV) areas and retinal neovascularization (RNV) in OIR. The area of resultant CNV post-laser rupture of Bruch’s membrane was analysed using fluorescein angiography at day D7 and D14. Vegfa gene locus recombination, VEGF protein levels and mRNA levels of Vegfa, Hif1a and Hif2a were analysed using genomic PCR, ELISA and quantitative RT-PCR respectively. Flow cytometry was used to isolate and analyse myeloid subsets. The t test and ANOVA were used for statistical analysis.

Results : Immunofluorescence and flow cytometry on reporter lines confirmed that Cre-targeted myeloid cells accumulate at sites of RNV and CNV. The Vegfa+/LacZ reporter and ISH showed that Vegfa is highly expressed by several cell types, but not by myeloid cells. The Lysm+/Cre allele did not affect the extent of AV, RNV or CNV. Conditional deletion of Vegfa, Hif1a and Hif2a was confirmed at genomic and transcript level (P<0.05). Myeloid-specific VEGF ablation did not reduce total ocular VEGF during CNV and RNV (P>0.05). In agreement, the deletion of Vegfa, Hif1a or Hif2a in recruited and resident myeloid cells that accumulated at sites of neovascularisation did not significantly reduce CNV or RNV (P>0.05).

Conclusions : These findings show that myeloid-derived HIF1α, HIF2α and VEGF are not significant in these mouse models of ONV, suggesting that myeloid function and VEGF production in neovascular eye disease differs from wound healing and other neovascular pathologies.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×